Updated
Updated · The New York Times · Aug 21
Harvard NIH Funding Trails Biden-Era Pace by 18% as Trump Conflict Shifts Tactics
Updated
Updated · The New York Times · Aug 21

Harvard NIH Funding Trails Biden-Era Pace by 18% as Trump Conflict Shifts Tactics

1 articles · Updated · The New York Times · Aug 21

Summary

  • Harvard’s National Institutes of Health funding is running about 18% below its average Biden-era grant pace, according to a New York Times analysis of government data.
  • The shortfall has persisted even after a federal judge forced the Trump administration last year to reverse drastic cuts, suggesting pressure has moved from headline freezes to quieter grant delays, reductions and rejections.
  • NIH actions are often leaving Harvard researchers and administrators unclear about what is happening, making the funding squeeze harder to challenge in court.
  • The slowdown follows Harvard’s successful lawsuit after the government announced a freeze of more than $2.2 billion in 2025 from multiple federal agencies, and points to a more subtle new phase in Trump’s fight with elite universities.

Insights

What happens to global medical innovation when federal agencies suddenly refuse to fund research that influences public health policies?